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LETTER TO THE EDITOR
مرض كوفيد-19 عند أطفال العراق
هل هو غري سائد أم مل يتم تقييم مدى انتشاره
Dear Editor,
Since the emergence of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2), in late December 2019 in Wuhan, China, the disease has infected hundreds of 
thousands of people worldwide. Its outbreak has led the World Health Organization (WHO) to announce a 
pandemic in March 2020.1 The disease affects primarily T-lymphocytes, particularly cluster of differentiation (CD) 
4+ and CD8+ T-cells, resulting in reducing the numbers and interferon-γ production by CD4+ T-cells. These 
immunological surrogate markers could be beneficial because of their association with the severity of COVID-19 
infection.2
Data on paediatric COVID-19 cases are rare. Recently published data suggests that children constitute 1–5% 
of diagnosed COVID-19 cases. In 90% of cases, the disease was diagnosed as asymptomatic, mild or moderate and 
deaths have been extremely rare. Up to 6.7% of cases might be severe but are generally seen in patients younger 
than 1 year of age and in those who have underlying diseases.3
The numbers of paediatric COVID-19 cases is a matter of concern in Iraq and worldwide. Due to financial 
constraints, testing for COVID-19 was introduced on the limited basis in Iraq utilising mainly rapid tests and to 
a lesser extent polymerase chain reaction tests of nasopharyngeal swabs. Although such limited testing capacity 
can’t precisely determine the actual case definition rate, 115,332 COVID-19 cases and 4,535 deaths were registered 
until July 29, 2020 in Iraq.4 The rise in COVID-19 cases is expected to continue based on different factors, notably 
active contact-tracing, increased testing capacity across the country and poor adherence to the guidelines of 
infection prevention measures as well as the loosening of movement-restrictions, particularly in impoverished and 
overcrowded areas. In Iraqi Kurdistan, four cases of paediatric COVID-19 were reported.5 However, across other 
parts of the country, 4,043 positive paediatric cases out of 946,761 tested samples were detected by July 28, 2020 
with a positivity rate of 0.4%.6
The actual rate of paediatric COVID-19 cases is underestimated in Iraq. The plausible explanations are 
manifold, namely (1) the milder clinical course of the disease in children compared to adults mimicking simple flu 
and, thus, these cases might escape the attention of treating paediatricians; (2) limited awareness of paediatricians 
about the disease itself; (3) popular misbeliefs/misinformation among the public on the seriousness of the disease; 
and (4) constrained laboratory testing capacity.
With the current state of the disrupted healthcare system in Iraq due to decades of conflict and underinvestment 
in healthcare services, the risks of potential paediatric COVID-19 infection in an already accelerating humanitarian 
crisis are multifaceted.7 Infected children represent an infection reservoir that might act as spreader of infection 
in the community. Available data suggests that vaccine preventable diseases in Iraq are still occurring in high 
incidence and causing outbreaks precipitated by the fluctuation in vaccine coverage (60–80%).8 The extended 
period of curfew affecting the implementation of national vaccination campaigns on one hand and the extended 
ban of international flights influencing the import of vaccines to Iraq on the other hand are expected to substantially 
put children at increased risk of missing routine vaccination schedules and devastate the suffering in the currently 
62 camps of refugees and internally displaced people across the country.
In these unprecedented times, the United Nations Children's Fund and the WHO could jointly play a pivotal 
role in improving the care for children in Iraq, saving their lives, defends their rights, help fulfil their potential and 
prevent the spread of the disease through application of the following measures: (1) promoting good nutrition and 
hygiene practices; (2) providing access to water, food, education and healthcare; (3) developing proper, friendly 
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information on COVID-19 to children and families; (4) recommending following national guidelines on COVID-19 
preventive measures such as physical distancing, hand washing and proper coughing and sneezing hygiene; (5) 
providing equipment and supplies for COVID-19 testing; and (6) importantly calling on the Iraqi government to 
invest more in healthcare services and intensify vaccination campaigns to cover children with missed vaccinations, 
once the COVID-19 pandemic is contained.
Early detection, registration, isolation, proper management of cases, increasing alertness of paediatricians 
and public and following infection prevention practices as well as vaccine development (solicited to be launched 
soon) represent the mainstay in the control of the paediatric cases of COVID-19 in Iraq.
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